Back
Rocket Pharmaceuticals, Inc. 10K Form
Sell
28
RCKT
Rocket Pharmaceuticals, Inc.
Last Price:
$3.43
Seasonality Move:
4.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RCKT News And Ratings
See the #1 stock for the next 7 days that we like better than RCKT
RCKT Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-50.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.90 |
| Price / Book: | 1.15 |
Profitability
| EPS (TTM): | -2.24760 |
|---|---|
| Net Income (TTM): | $-240.9M |
| Gross Margin: | $-9.4M |
| Return on Equity: | -64.31% |
| Return on Assets: | -55.22% |
Rocket Pharmaceuticals, Inc. Earnings Forecast
Key Rocket Pharmaceuticals, Inc. Financial Ratios
-
Per Share Earnings over the last 13 years have been positive in 7 years.
Rocket Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RCKT |
| CUSIP: | 77313F |
| Website: | rocketpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.08 |
|---|---|
| Current Ratio: | 7.3 |
| Quick Ratio: | 7.15 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RCKT Technical Analysis vs Fundamental Analysis
Sell
28
Rocket Pharmaceuticals, Inc. (RCKT)
is a Sell
Is Rocket Pharmaceuticals, Inc. a Buy or a Sell?
-
Rocket Pharmaceuticals, Inc. stock is rated a SellThe current Rocket Pharmaceuticals, Inc. [RCKT] share price is $3.42. The Score for RCKT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.